226 results on '"Kurth, Jens"'
Search Results
2. EANM position paper on challenges and opportunities of full-ring 360° CZT bone imaging: it’s time to let go of planar whole-body bone imaging
3. Cerebral glucose metabolic correlates of cognitive and behavioural impairments in amyotrophic lateral sclerosis
4. Multi-modal assessment of a cardiac stem cell therapy reveals distinct modulation of regional scar properties
5. Neurodegenerative und Demenzielle Erkrankungen
6. Support for the “Vancouver call for action to strengthen expertise in radiological protection worldwide”: the position of organisations in formal relations with the International Commission on Radiological Protection (ICRP)
7. Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature
8. Implementation of dosimetry for molecular radiotherapy; results from a European survey
9. Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer
10. Iterative learning control of a pneumatically actuated lung tumour mimic model for an improvement of PET/CT-imaging
11. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre
12. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F]F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation
13. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
14. PSMA-Based Therapy of Metastasized Castrate-Resistant Prostate Cancer
15. Impact of68 Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
16. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
17. Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival
18. Patient‐related benefits of amyloid PET imaging in unclear dementia: rationale and study design of the randomized ENABLE study
19. Interlinking potential therapy with botulinum neurotoxin-A and Parkinson's disease
20. Contributors
21. Preclinical Comparison of the64Cu- and68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT
22. Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE
23. Iterative Learning Control of a Pneumatically Actuated Lung Tumour Mimic Model
24. Longitudinal [18F]FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice
25. Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy.
26. [18F]GE-180-PET and Post Mortem Marker Characteristics of Long-Term High-Fat-Diet-Induced Chronic Neuroinflammation in Mice
27. Prostate cancer imaging and therapy
28. Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer.
29. Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT.
30. Dosimetrie diagnostischer Radiopharmaka und Diagnostische Referenzwerte in der Nuklearmedizin
31. Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity, and the effect of hematological toxicity on survival
32. Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature.
33. Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer
34. Comparison of [11C]Choline ([11C]CHO) and [18F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model
35. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5
36. Molecular imaging of dementia
37. [ 18 F]GE-180-PET and Post Mortem Marker Characteristics of Long-Term High-Fat-Diet-Induced Chronic Neuroinflammation in Mice.
38. Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy
39. Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractory auditory hallucinations and major self-mutilation
40. Comparison of [11C]Choline ([11C]CHO) and S(+)-β-Methyl-[11C]Choline ([11C]SMC) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model
41. GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals
42. Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
43. Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study.
44. Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
45. DGN-Handlungsempfehlung (S1-Leitlinie) – PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms – Stand: 01/2022 – AWMF-Registernummer: 031-055.
46. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F]F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation
47. Standardization of MRI and Amyloid Imaging
48. List of Contributors
49. Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
50. 68Ga-labelled tropane analogues for the visualization of the dopaminergic system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.